Page last updated: 2024-09-05

org 31710 and cyclin d1

org 31710 has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies
(org 31710)
Trials
(org 31710)
Recent Studies (post-2010)
(org 31710)
Studies
(cyclin d1)
Trials
(cyclin d1)
Recent Studies (post-2010) (cyclin d1)
383610,885705,157

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornish, AL; Lee, CS; Musgrove, EA; Sutherland, RL; Swarbrick, A1

Other Studies

1 other study(ies) available for org 31710 and cyclin d1

ArticleYear
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:1

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance; Estrenes; Furans; Hormone Antagonists; Humans; Mifepristone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogene Proteins; Phosphorylation; Progestins; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Retinoblastoma Protein; Tumor Cells, Cultured

1997